BioIQ Announces New Saliva Test for COVID-19
New saliva test helps address current national sample collection and personal protective equipment (PPE) supply chain shortages
ATLANTA, March 31, 2020 /PRNewswire/ -- BioIQ, a healthcare engagement and clinical adherence technology platform company, announces production of a saliva-based COVID-19 test. Developed through the company's integrated lab network in strict adherence to FDA guidelines, the new test will be available as early as next week for use with clinician oversight in a clinical setting. This solution increases testing capacity, improves access to testing and minimizes waste around the utilization of critical personal protective equipment (PPE) supplies.